LQ7-81758-99411
3 vaccinations
6 coded responses
20 check-ins
6 free-text entries
5 call cases
- Sex
- —
- Age at first dose
- 46-50
- ZIP prefix
- 731 / OK
- Registered
- 2021-01-22
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-22
Registered in v-safe
-
2021-01-22
Dose 1 — Moderna
- 2021-01-23
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-02-07
-
2021-02-19
Dose 2 — Moderna
- 2021-02-19
-
2021-02-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness, Swelling · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
-
2021-02-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-02-26
-
2021-03-07
Survey response — day 14, dose 2MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-14
Survey response — day 21, dose 2MedDRA: Abdominal pain — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Abdominal crampingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-14
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-19
-
2021-03-26
Survey response — day 35, dose 2MedDRA: Rash — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: RashMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Report sent to call center — day 35, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-04
Survey response — day 42, dose 2MedDRA: Rash — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: RashMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-04
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-21
- 2021-06-17
-
2021-06-17
Callback requested for4:00PM ET
-
2021-08-22
Survey response — 6 months, dose 2MedDRA: Gastrointestinal disorder — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: GI issuesMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-22
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-09-11
Dose 3 — Moderna
-
2022-02-19
Survey response — 12 months, dose 2MedDRA: Asthma, Vision blurred — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Asthmatics, blurred visionMedDRA releases: 2024-11 · check-in free text available
-
2022-02-19
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-22
Call successfulReported to VAERS voluntarily prior to GDIT contact
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-22 | Moderna | |
| 2 | 2021-02-19 | Moderna | |
| 3 | 2021-09-11 | Moderna | No |
Call center
5 call center cases
5 successful
VAERS report filed, before or during a call: 5
Free text
Release 5 — day 14, dose 2
Symptoms: Fatigue
Release 5 — day 21, dose 2
Symptoms: Abdominal cramping
Release 6 — day 35, dose 2
Symptoms: Rash
Release 6 — day 42, dose 2
Symptoms: Rash
Release 9 — 6 months, dose 2
Symptoms: GI issues
Release 11 — 12 months, dose 2
Symptoms: Asthmatics, blurred vision
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | ✓ | ✓ | ✓ |
| SD | Asthma | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gastrointestinal disorder | ✓ | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Vision blurred | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release